Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +1.51% | +0.58% |
13/05 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
10/05 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
Evolution of the average Target Price on Organogenesis Holdings Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Organogenesis Holdings Inc.
Morgan Stanley | |
BTIG | |
Oppenheimer | |
SVB Leerink | |
Credit Suisse |
EPS Revisions
- Stock Market
- Equities
- ORGO Stock
- AHPAU Stock
- Consensus Organogenesis Holdings Inc.